Pharma offense is best reform defense

You know that pharma is joining the health-reform effort this time around, probably because company execs know they can't beat it completely. And you know that they're using that seat at the table to promote changes that they consider pharma-friendly. For lots more on drugmakers' offense-is-the-best-defense approach, check out the Wall Street Journal analysis. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.